Tianshui Zhongxing Bio-technology (002772.SZ) plans to repurchase shares worth 80 million to 150 million yuan. It has obtained a commitment for a loan of not more than 100 million yuan from China Minsheng Banking Corp., Ltd.
China Sinopharm International Corporation (002772.SZ) announced that the company plans to repurchase shares worth 80 million to 150 million yuan, in order to...
Tianshui Zhongxing Bio-technology (002772.SZ) announced that the company plans to repurchase shares with an amount ranging from 80 million to 150 million RMB, at a repurchase price not exceeding 10 RMB per share. The funds for the share repurchase will be sourced from the company's own funds and specialized loan funds for stock repurchase. China Minsheng Banking Corp., Ltd. Lanzhou Branch has issued a "Special Loan Commitment Letter for Stock Repurchase" to the company, promising to provide specialized loan support for the company's share repurchase, with a loan amount not exceeding 100 million RMB and a loan term of 1 year.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


